Anuncio
Anuncio

TRVI

TRVI logo

Trevi Therapeutics, Inc. Common Stock

16.98
USD
Patrocinado
+0.61
+3.73%
18 jun, 15:14 UTC -4
Apertura

Panorámica financiera de Trevi Therapeutics, Inc. Common Stock

Cap. de Mercado
2.41B
Beta
0.99
Beneficios Por Acción (BPA)
-0.32
Ratio Precio/Valor (P/V) Contable
9.31
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
-25.49%
Ratio de liquidez
19.66%
Flujo de caja libre
-42.10M
Perfil de TRVI

Gráfico de Beneficios

Beneficios de TRVI

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$1138.95
+9.18%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$179.72
-6.31%
Nvidia Corp logo
Nvidia Corp$210.03
+2.63%
Intel Corp logo
Intel Corp$133.90
+10.57%
Marvell Technology, Inc. Common Stock logo
Marvell Technology, Inc. Common Stock$326.26
+12.68%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$2165.85
+10.57%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$394.38
-0.50%
Anuncio